Neupro (rotigotine)-Important Information from UCB (Pharma) on the recall of certain packs

Notice type: 3rd Party Publications

Date: 11/06/2008

Problem Or Issue:
Please find herewith an important safety notification from UCB (Pharma) Ireland Limited relating to the manufacture of Neupro (rotigotine transdermal patch) which resulted in a recall of certain affected batches of the product across Europe. Neupro is indicated for the treatment of the signs and symptoms of early-stage and advanced-stage idiopathic Parkinson's disease.

« Back